Log in
Enquire now
‌

POTOMAC AFFINITY PROTEIN, LLC SBIR Phase II Award, July 2019

A SBIR Phase II contract was awarded to POTOMAC AFFINITY PROTEIN, LLC in July, 2019 for $760,681.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

OverviewStructured DataIssuesContributors

Contents

sbir.gov/node/1689693
Is a
SBIR/STTR Awards
SBIR/STTR Awards

SBIR/STTR Award attributes

SBIR/STTR Award Recipient
‌
POTOMAC AFFINITY PROTEIN, LLC
0
Government Agency
0
Government Branch
National Institutes of Health
National Institutes of Health
0
Award Type
SBIR0
Contract Number (US Government)
2R44GM126676-020
Award Phase
Phase II0
Award Amount (USD)
760,6810
Date Awarded
July 1, 2019
0
End Date
June 30, 2021
0
Abstract

Project Summary: Our long-term objective is to commercialize a fast, simple, flexible, and economical system for affinity-tag protein purification and tag removal. This technology was developed as a result of NIH-funded studies on the folding, stability and enzymology of the Bacillus protease subtilisin. The transformative purification technology combines three components: 1) a regulated, highly-specific protease (Psub) that is constitutively inactive; 2) a small molecule (imidazole) that activates the Psub; 3) a high-affinity inhibitor (Pro). Immobilized Psub (in the off-state) can capture a Pro-fusion protein from a cellular extract, allowing contaminants to be washed away. Subsequent addition of imidazole to the immobilized complex releases pure, tag-free target protein and leaves the Pro-tag tightly bound to Psub. Recombinant proteins are frequently fused with other proteins or peptides to facilitate expression and purification. The tags enable target protein binding in affinity purification, but ultimately must be processed by a site-specific protease. Tag removal, however, is frequently expensive, inefficient, and sometimes problematic. The technical innovation of our system is the integration of seamless tag removal into the purification process. This provides simplicity, efficiency, and robustness that is not available in any other system. Improved understanding of protein engineering principles has resulted in highly-efficient Psubs and Pro affinity tags. The experimental plan has two goals. The first is to generate economical materials for purification of standard proteins without tags. The second goal more ambitious goal is to develop methods for purifying high-value proteins that are either difficult or impossible with current methods. The Specific Aims are: 1) Evaluation of site-specific immobilization methods for Psub; 2) Cloning of challenging, high-value target proteins; 3) Expression-extraction-purification of high-value target proteins; 4) Optimization of the purification of challenging proteins; 5) Testing physical and biological properties of purified proteins. Better purification technology should advance in all areas of biology but have a particular impact on the production of growth factors needed for the growth, survival, and differentiation of therapeutic cells.Project Narrative: Challenges in protein purification limit progress in biology and medicine. The purification technology being developed in this project should help advance in all areas of biology but have a particular impact on the production of growth factors needed for the growth, survival, and differentiation of therapeutic cells.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like POTOMAC AFFINITY PROTEIN, LLC SBIR Phase II Award, July 2019

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.